The Top Pharma List rankings are compiled from GlobalData's
pharmaceutical revenue figures, which are based on prescription medicine
sales, including generics drugs.
order to pay down a very high level of debt stemming from its $39bn acquisition of Allergan’s generics business Actavis in 2015.
Most recently, Corcoran served as chief medical officer at Allergan and before that he was Actavis’ chief medical officer.
The $64bn sum makes the deal the biggest pharma M&A transaction since Actavis bought Allergan in 2015 for $70.5bn.
Analysts suggest however that negative sentiment could still scupper a deal that is by far the largest ever undertaken by the company - and the biggest in pharma since the $70bn
Allergan - also headquartered in Ireland - is no stranger to the M&A game having been bulked up by serial acquisitions in recent years, including a $66bn merger with Actavis in 2014
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....